NEW YORK (Reuters Health) – N-acetylcysteine is increasingly used to prevent contrast-induced nephropathy (CIN) but it is not effective, according to a paper in JACC: Cardiovascular Interventions for…
NEW YORK (Reuters Health) – Percutaneous placement of a sirolimus-eluting stent (SES) is a safe and effective way to address either bare-metal (BMS) or drug-eluting (DES) in-stent restenosis,…
NEW YORK (Reuters Health) – Patients on beta-blockers who undergo surgery are nearly twice as likely to experience adverse events in the following months if beta-blockers are discontinued,…
NEW YORK (Reuters Health) – Intravenous immunoglobulin therapy started 10 days or more after onset of Kawasaki disease (KD) suppresses inflammation but does not prevent coronary artery lesions,…
NEW YORK (Reuters Health) – The rate of radial artery occlusion after transradial catheterization increases with the size of arterial sheath used for the procedure, according to data…
NEW YORK (Reuters Health) – There is no solid evidence that drug-eluting stents (compared to bare-metal stents) increase the risk for stent thrombosis, death or myocardial infarction in…
NEW YORK (Reuters Health) – Contrary to traditional thinking, endarterectomy for carotid stenosis can be performed safely in patients with a history of cervical radiation therapy, and carotid…
NEW YORK (Reuters Health) – A direct comparison of four agents as monotherapy in drug-naive patients with type 2 diabetes shows that exenatide once-weekly, metformin, and pioglitazone provide…
NEW YORK (Reuters Health) – Silent embolic cerebral infarctions occur in about 1 in 6 patients after undergoing coronary angiography, and the risk is related to the degree…
NEW YORK (Reuters Health) – Data released online today in the Journal of the American Medical Association challenge current guidelines for maintaining potassium levels immediately after a heart…